胆胰疾病的个体化ERCP治疗价值探讨  

Individual application of therapeutic ERCP in biliary-pancreatic diseases

作　　者：牛桂军[1] 陈卓琳[1] 张启芳[1] 陈勇昌[1] 叶家琳[1] 马玲玲[1] 

机构地区：[1]广西壮族自治区南溪山医院消化内科,广西桂林541002

出　　处：《华夏医学》2010年第3期248-251,共4页Acta Medicinae Sinica

摘　　要：目的:探讨个体化治疗性ERCP对胆胰疾病的治疗价值。方法:回顾性分析10年来316例患者的ERCP治疗临床资料。结果:本组患者ERCP治疗的总成功率为94.6%(299/316)。计胆总管结石EST 227例,EST后取石成功率94.7%(215/227);60例恶性胆道梗阻中,56例行ERBD成功(56/60,93.3%)。行ENBD者绝大部分成功。主要并发症是急性胰腺炎、胆道感染,其次为出血、心肺功能障碍。结论:治疗性ERCP对多种胆胰疾病疗效确实。内镜下个体化原则治疗胆胰疾病安全可行。Objective：To evaluate the role of individual therapeutic ERCP in the treatment of biliarpancreatis diseases.Methods：A total of 316 patients who underwent therapeutic ERCP from July 2000 to May 2010 were analyzed retrospectively.Results：The total success rate was 94.6%（299/316）.215 were successful among the 227 cases of choledocholithiasis（94.7%）,and 56 of the 60 cases with malignant bile duct or pancreatic duct stenosis with stent placement were successful（93.3%）.Endoscopic nasobiliary drainage was successful in most cases.The major complication of therapeutic ERCP was acute pancreatitis and cholangitis, the next was hemorrhage and cardiopulmonary events.Conclusion： ERCP is one of the major therapeutic methods for biliary-pancreatic diseases.Therapeutic ERCP is a minimally invasive,safe and effective treatment method for various biliary-pancreatic diseases.

关 键 词：内镜逆行胰胆管造影术 个体化治疗 胆胰疾病 

分 类 号：R657.4[医药卫生—外科学] R657.5[医药卫生—临床医学]